Clinical Laserthermia Systems AB (publ)

Stockholm Stock Exchange CLS-B.ST

Clinical Laserthermia Systems AB (publ) Receivables for the year ending December 31, 2023: USD 260.47 K

Clinical Laserthermia Systems AB (publ) Receivables is USD 260.47 K for the year ending December 31, 2023, a -67.53% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.

Clinical Laserthermia Systems AB (publ) Receivables for the year ending December 31, 2022 was USD 802.20 K, a 12.92% change year over year.
Clinical Laserthermia Systems AB (publ) Receivables for the year ending December 31, 2021 was USD 710.39 K, a 0.00% change year over year.
Clinical Laserthermia Systems AB (publ) Receivables for the year ending December 31, 2020 was USD 0.00, a 0.00% change year over year.
Clinical Laserthermia Systems AB (publ) Receivables for the year ending December 31, 2019 was USD 0.00, a -100.00% change year over year.

Key data

Date	Receivables	Inventory	Goodwill	Total Assets

Stockholm Stock Exchange: CLS-B.ST

Clinical Laserthermia Systems AB (publ)

CEO	Mr. Dan Johansson Mogren
IPO Date	April 16, 2009
Location	Sweden
Headquarters	Building 405
Employees	17
Sector	Technology
Industries 3D Printing Biotechnology Composite Materials Eyewear Glass Medical Instruments Personal Care Pollution Treatment

Description

Clinical Laserthermia Systems AB (publ) develops treatment tools for diseased tissue under the TRANBERG brand in Sweden. The company offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. It also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers provides multiple options to control treatment. In addition, the company offers various gauge laser applicators, as well as provides temperature and treatment monitoring devices. Clinical Laserthermia Systems AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden.

Key trends

Past 5 years